Hemp & Health SA is engaged in hemp and cannabis cultivation. The company processes harvested crops such as CBD and CBG, used for the production of white labels and private labels oils, creams, dried herbs and liquids for vaporization.
2011
1
Last FY Revenue $34K
Last FY EBITDA -$0.3M
$6.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Hemp & Health achieved revenue of $34K and an EBITDA of -$0.3M.
Hemp & Health expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Hemp & Health valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | $34K | XXX | XXX | XXX |
Gross Profit | XXX | $16K | XXX | XXX | XXX |
Gross Margin | XXX | 48% | XXX | XXX | XXX |
EBITDA | XXX | -$0.3M | XXX | XXX | XXX |
EBITDA Margin | XXX | -826% | XXX | XXX | XXX |
EBIT | XXX | -$0.3M | XXX | XXX | XXX |
EBIT Margin | XXX | -851% | XXX | XXX | XXX |
Net Profit | XXX | -$0.3M | XXX | XXX | XXX |
Net Margin | XXX | -873% | XXX | XXX | XXX |
Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Hemp & Health's stock price is PLN 0 (or $0).
Hemp & Health has current market cap of PLN 25.0M (or $6.6M), and EV of PLN 22.6M (or $6.0M).
See Hemp & Health trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$6.0M | $6.6M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Hemp & Health has market cap of $6.6M and EV of $6.0M.
Hemp & Health's trades at 176.3x EV/Revenue multiple, and -21.3x EV/EBITDA.
Equity research analysts estimate Hemp & Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Hemp & Health's P/E ratio is not available.
See valuation multiples for Hemp & Health and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $6.6M | XXX | $6.6M | XXX | XXX | XXX |
EV (current) | $6.0M | XXX | $6.0M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | 176.3x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | -21.3x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | -20.7x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | -22.3x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | -12.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialHemp & Health's revenue per employee in the last FY averaged $34K, while opex per employee averaged $0.3M for the same period.
Hemp & Health's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Hemp & Health's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Hemp & Health and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | -826% | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $34K | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 899% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Hemp & Health acquired XXX companies to date.
Last acquisition by Hemp & Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Hemp & Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Hemp & Health founded? | Hemp & Health was founded in 2011. |
Where is Hemp & Health headquartered? | Hemp & Health is headquartered in Poland. |
How many employees does Hemp & Health have? | As of today, Hemp & Health has 1 employees. |
Is Hemp & Health publicy listed? | Yes, Hemp & Health is a public company listed on WAR. |
What is the stock symbol of Hemp & Health? | Hemp & Health trades under HMP ticker. |
When did Hemp & Health go public? | Hemp & Health went public in 2012. |
Who are competitors of Hemp & Health? | Similar companies to Hemp & Health include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
What is the current market cap of Hemp & Health? | Hemp & Health's current market cap is $6.6M |
Is Hemp & Health profitable? | Yes, Hemp & Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.